ARTICLE | Clinical News
Neugenesis regulatory update
April 15, 2013 7:00 AM UTC
Neugenesis, which develops fungal systems for engineering and production of mammalian proteins, received notice of allowance for a U.S. patent covering its technology to express heteromeric (multi-sub...